Intelligent Paratransit

Kaufman, Sarah; Ashley Smith; Jenny O'Connell; Ari Kaputkin Read more

Updating the Toxic Substances Control Act to Protect Human Health

Leonardo Trasande Read more

Mobility, Economic Opportunity and New York City Neighborhoods

Sarah M. Kaufman, Mitchell L. Moss, Jorge Hernandez and Justin Tyndall Read more

Information Visibility in Humanitarian Operations: Current State-of-the-Art

Privett, N. Read more

Monitoring the pulse of hospital activity: Electronic health record utilization as a measure of care intensity

Blecker, S., J.S. Austrian, D. Shine, R. Scott Braithwaite, M.J. Radford, and M.N. Gourevitch Read more

Test–retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients

McNeely, J., S.M. Strauss, S. Wright, J. Rotrosen, R. Khan, J.D. Lee, and M.N. Gourevitch Read more

Prostate Specific Antigen at the Initial Diagnosis of Metastasis to Bone in Patients After Radical Prostatectomy

Loeb, S., D.V. Makarov, E.M. Schaeffer, E.B. Humphreys, and P.C. Walsh Read more

Validation of the Partin Nomogram for Prostate Cancer in a National Sample

Yu, J.B., D.V. Makarov, R. Sharma, R.E. Peschel, A.W. Partin, and C.P. Gross Read more

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

Isharwal, S., D.V. Makarov, H.B. Carter,J.I. Epstein, A.W. Partin, P. Landis, C. Marlow, and R.W. Veltri Read more

Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score

Huang, Y., S. Isharwal, A. Haese, F.K.H. Chun,D.V. Makarov, Z. Feng, M. Han, E. Humphreys, J.I. Epstein, A.W. Partin, and R.W. Veltri Read more
Subscribe to Technology & Policy